Correlation Between Abcellera Biologics and Chimerix
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Chimerix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Chimerix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and Chimerix, you can compare the effects of market volatilities on Abcellera Biologics and Chimerix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Chimerix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Chimerix.
Diversification Opportunities for Abcellera Biologics and Chimerix
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Abcellera and Chimerix is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Chimerix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chimerix and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Chimerix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chimerix has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Chimerix go up and down completely randomly.
Pair Corralation between Abcellera Biologics and Chimerix
Given the investment horizon of 90 days Abcellera Biologics is expected to under-perform the Chimerix. In addition to that, Abcellera Biologics is 1.06 times more volatile than Chimerix. It trades about -0.05 of its total potential returns per unit of risk. Chimerix is currently generating about -0.03 per unit of volatility. If you would invest 199.00 in Chimerix on September 3, 2024 and sell it today you would lose (111.00) from holding Chimerix or give up 55.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Abcellera Biologics vs. Chimerix
Performance |
| Timeline |
| Abcellera Biologics |
| Chimerix |
Abcellera Biologics and Chimerix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Abcellera Biologics and Chimerix
The main advantage of trading using opposite Abcellera Biologics and Chimerix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Chimerix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chimerix will offset losses from the drop in Chimerix's long position.| Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
| Chimerix vs. Assembly Biosciences | Chimerix vs. Spero Therapeutics | Chimerix vs. Achilles Therapeutics PLC | Chimerix vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |